Jigar Raythatha

Jigar Raythatha has served as a director on the board of directors since September 2021, and as the chairman of the board of directors since June 2022. Mr. Raythatha served as the chief executive officer of Constellation Pharmaceuticals, Inc. from 2017 until its acquisition by MorphoSys AG in July 2021. Mr. Raythatha is also currently a member of the American Cancer Society New England Area Board. Before joining Constellation as chief executive officer, Mr. Raythatha served as chief business officer of Jounce, where he helped build the company from inception to a 100-person, publicly traded organization. Earlier in his career, Mr. Raythatha worked with Red Abbey Venture Partners and held roles of increasing responsibility at Biogen and as a management consultant at A.T. Kearney. Mr. Raythatha holds an M.B.A. from Columbia Business School and a B.A. in Economics, Molecular Biology and Biochemistry from Rutgers University.